Different pools, different yardsticks, so dont read them as one figure, but the direction holds
It's a watershed move that could unlock a vast new patient population for Novo Nordisk and Eli Lilly and dramatically expand access to medications that were previously out of reach for many people ages 65 and above
Licensure & Registration: Policies & Protocols: Technology & Documentation: State-Specific Requirements: Clinical Competence: Initial Evaluation: Ongoing Management: Lets be honest about the business case, because adding weight management to a psychiatric practice isnt trivial
Familiarizing yourself with common terms and identifying specific medications you're interested in can make the discussion more productive
Many prescribers recommend transitioning to a maintenance dose to support your continued success beyond GLP-1 treatment
The most common GLP-1 injections available in the UK include semaglutide (sold as Wegovy for weight loss and Ozempic for diabetes), liraglutide (Saxenda), and tirzepatide (Mounjaro)